Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CCL17 antibodies

Anti-CCL17 antibodies

US Patent 11414484 · Granted Aug 16, 2022

Estimated economic value: $350,717,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Artificial cell death polypeptide for chimeric antigen receptor and uses thereof2025
Anti-PHF-tau antibodies and uses thereof2025
Anti-PHF-tau antibodies and uses thereof2025
Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses2024
Variable heavy chain only libraries, methods of preparation thereof, and uses th2024
Individualized gym facility and related methods2024
Chimeric antigen receptor system with adaptable receptor specificity2024
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D an2024
Materials and methods for improved single chain variable fragments2023
Neutralizing human anti-CD27 antibodies2023
Neutralizing human anti-CD27 antibodies2023
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D an2023